Treatment for digestive issues after acute pancreatitis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of a 6-month treatment with pancrelipase (CREON) for adults suffering from exocrine pancreatic insufficiency (EPI) following an episode of acute pancreatitis. Participants will undergo a 7-day run-in period without pancreatic enzyme replacement therapy, followed by a 180-day treatment phase with pancrelipase. The study will assess symptom improvement through blood and stool analysis, as well as health status surveys, concluding with a 30-day post-treatment observation period to monitor safety and symptom burden.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Adult patients of age 18 or older, able to provide informed consent and follow all study procedures.
2. Stable outpatient up to 12 months following an acute pancreatitis episode and has EPI based on an FE-1 \< 200 µg/g stool obtained within 3 months prior to baseline assessment (Visit 2).
3. Score of equal or greater 0.6 on the EPI symptom tracker at baseline Visit 2.
4. Must be off PERT (including prescription and non-prescription enzymes) for 7 days prior to baseline Visit 2.
5. Must have fully completed the terminal intervention for necrotizing pancreatitis (surgical or endoscopic necrosectomy or percutaneous drainage).
6. Have a Body Weight between 40 and 120 kg (amounts to 600-1800 LU/meal pancrelipase starting dose of pancrelipase).
7. Women of childbearing potential must have a negative urine pregnancy test at Study Day 1 and practicing at least one protocol specified method of birth control (Section 5.2.4), starting at Study Day 1 through 30 days after last dose of pancrelipase.
8. Females of non-childbearing potential (either postmenopausal or permanently surgically sterile as defined:

   * Age \> 55 years with no menses for 12 or more months without an alternative medical cause.
   * Age ≤ 55 years with no menses for 12 or more months without an alternative medical cause AND an FSH level \> 40 IU/L.

OR

* Permanently surgical sterile (bilateral oophorectomy, bilateral salpingectomy or hysterectomy).

do not require pregnancy testing.

Exclusion Criteria:

1. Acute pancreatitis episode due to a pancreatic cystic neoplasm, trauma, or surgery. Post-ERCP acute pancreatitis patients can be enrolled.
2. History of definite chronic pancreatitis defined by APA Chronic Pancreatitis Guideline.1
3. Pancreas malignancy or other active malignancies requiring systemic treatment; treated basal cell carcinoma, and treated in-situ cervical cancer can be included.
4. Enteropathies, and gastroenteritis that may affect FE-1 levels, e.g., Inflammatory bowel disease, Celiac Disease, viral-, bacterial-, fungal-, or parasitic gastroenteritis.
5. Gastroparesis.
6. Confirmed or suspected cystic tumor associated with main pancreatic duct dilation or believed to be the cause of AP (in the site-PI's judgment).
7. Prior pancreatic surgery or GI tract surgery affecting the upper GI tract including but not limited to gastric bypass surgery, total pancreatectomy.
8. Pregnancy or breast feeding.
9. Patients with life expectancy of less than 6 months due to advanced chronic conditions, such as congestive heart failure or chronic obstructive pulmonary disease, or other conditions which preclude study participation by judgement of the investigator.
10. Incarcerated individuals

Where it's running

• University of Southern California
  Los Angeles, California, United States Recruiting
• University of Illinois Chicago
  Chicago, Illinois, United States Recruiting
• The Ohio State University
  Columbus, Ohio, United States Recruiting
• University of Pittsburgh
  Pittsburgh, Pennsylvania, United States Recruiting
• University of Minnesota
  Minneapolis, Minnesota, United States Not yet recruiting
• New York University Langone Medical Center
  New York, New York, United States Withdrawn

Study contacts

• Study coordinator: Zoe Krebs
• Email: zoe.krebs@osumc.edu
• Phone: 614-685-3619

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Blood test to find mild-to-moderate pancreatic enzyme insufficiency and guide enzyme treatment for people with pancreatitis

  This project will use the Malabsorption Blood Test to find adults with recurrent acute or chronic pancreatitis who have mild-to-moderate exocrine pancreatic insufficiency and see if pancreatic enzyme replacement for responsive patients improves quality of life.

  Recruiting Phase 4 University of Pittsburgh · Baltimore, Maryland and 1 other locations · NCT07418593

• Global Shwachman-Diamond Syndrome Patient Survey and Collaboration Platform

  An online program for people with Shwachman-Diamond Syndrome and their families to share health experiences, join a global community, and receive early information about research and clinical opportunities.

  Recruiting Shwachman-Diamond Syndrome Alliance Inc · Woburn, Massachusetts · NCT06999954

• Arthrocentesis with ACL Reconstruction for Acute ACL Tears

  This trial tests whether draining the knee before and after ACL reconstruction helps reduce inflammation, prevent muscle loss, and speed recovery in people with a recent ACL tear.

  Recruiting at 2 sites Ohio State University · Columbus, Ohio and 1 other locations · NCT07929922

• Restoring Emotional Balance With Ketones for Women After Birth

  This study tests whether taking a ketone supplement plus group cognitive-behavioral counseling and guided exercise can help women within 12 months after birth who have postpartum depression feel better.

  Recruiting Ohio State University · Columbus, Ohio · NCT07919392

• Do dual-focus multifocal contact lenses improve hand-eye coordination and sports vision compared with your usual lenses

  This study tests whether wearing dual-focus multifocal contact lenses improves hand-eye coordination and sports vision in adults who play baseball or softball and normally wear contact lenses.

  Recruiting Ohio State University · Columbus, Ohio · NCT07840209

• New Generation Therapies for Suicide: Refining Brief Cognitive Behavioral Therapy

  This study tests different sequences and doses of Brief Cognitive Behavioral Therapy to see if it better reduces suicide risk in adults with recent suicidal thoughts or behavior.

  Recruiting Ohio State University · Columbus, Ohio · NCT07818889

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.